Kobayashi Tatsuya, Kida Yoshihisa, Mori Yoshimasa
Department of Neurosurgery, Gamma Knife Center, Komaki City Hospital, Komaki City, Japan.
J Neurosurg. 2002 Dec;97(5 Suppl):422-8. doi: 10.3171/jns.2002.97.supplement.
The authors sought to analyze the long-term outcome of patients with Cushing disease who underwent gamma knife radiosurgery (GKS) as either an adjuvant or primary treatment.
Twenty-five patients with Cushing disease were treated by OKS and followed for more than 2.5 years (mean 5.3 years). The overall results showed a complete response rate of 30%, a response rate of 85%, and a tumor control rate of 100%. Tumor size and radiation dose were the most important factors related to the treatment response. The complete response rate for microadenomas and small adenomas was significantly higher than that for macroadenomas. An 83.2% complete response rate was obtained using a maximum dose of more than 55 Gy and/or a margin dose of more than 40 Gy. Serum adrenocorticotropic hormone and cortisol levels were normalized in 35% of patients, decreased significantly in 60%, and decreased in 85%. Fifty-one of 85 characteristic signs and symptoms of Cushing disease improved without any side effects. The overall outcome was excellent in seven cases, good in six, fair in four, and poor in four cases; one patient died. The initial treatment was GKS in four patients, two of whom had a complete response and two of whom had a partial response. Hormone levels returned to normal in the patients in whom there was a complete response. The results in the six patients in whom Nelson syndrome was present were less favorable; the response rate was only 33%, although the control rate was 100%. Hormone levels decreased in two patients.
Gamma knife radiosurgery is safe and effective for the treatment of Cushing disease as an adjuvant or initial therapy when selective and accurate dose planning is performed.
作者试图分析接受伽玛刀放射外科手术(GKS)作为辅助或主要治疗的库欣病患者的长期预后。
25例库欣病患者接受了伽玛刀放射外科手术治疗,并随访超过2.5年(平均5.3年)。总体结果显示完全缓解率为30%,缓解率为85%,肿瘤控制率为100%。肿瘤大小和放射剂量是与治疗反应相关的最重要因素。微腺瘤和小腺瘤的完全缓解率显著高于大腺瘤。使用最大剂量超过55 Gy和/或边缘剂量超过40 Gy可获得83.2%的完全缓解率。35%的患者血清促肾上腺皮质激素和皮质醇水平恢复正常,60%显著下降,85%有所下降。85项库欣病特征性体征和症状中的51项得到改善,且无任何副作用。总体预后:7例为优,6例为良,4例为中,4例为差;1例患者死亡。4例患者初始治疗为伽玛刀放射外科手术,其中2例完全缓解,2例部分缓解。完全缓解患者的激素水平恢复正常。6例患有尼尔森综合征的患者结果较差;缓解率仅为33%,尽管控制率为100%。2例患者激素水平下降。
当进行选择性和精确的剂量规划时,伽玛刀放射外科手术作为辅助或初始治疗用于库欣病的治疗是安全有效的。